AKT3 and pancreatic adenocarcinoma: In-silico database analyses using cBioPortal (https://www.cbioportal.org) for pancreatic adenocarcinoma (QCMG, Nature 2016) [55] (data not shown) revealed an increased AKT3 expression in KRAS mutated PDAC tumor samples compared to non-mutated samples.